Science Explorer Interactive view Map
Company · Solan · India

Magbro Healthcare (India)

Research works
1
fractional, all time
Citations
2
1.9 per fractional work
Top-10% rate
18.5%
record average 16.5%
Open access
81%
world 28%

Not ranked overall: Magbro Healthcare (India) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Magbro Healthcare (India) publish most on?

By volume in 2022–2025: Multiple Myeloma Research and Treatments, Hereditary Neurological Disorders, Immunodeficiency and Autoimmune Disorders and Autoimmune and Inflammatory Disorders Research.

  1. 1 Multiple Myeloma Research and Treatments Hematology 0 works
  2. 2 Hereditary Neurological Disorders Cellular and Molecular Neuroscience 0 works
  3. 3 Immunodeficiency and Autoimmune Disorders Immunology 0 works
  4. 4 Autoimmune and Inflammatory Disorders Research Hematology 0 works
  5. 5 Neurogenetic and Muscular Disorders Research Genetics 0 works
  6. 6 CAR-T cell therapy research Oncology 0 works
  7. 7 Chemokine receptors and signaling Oncology 0 works
  8. 8 Cancer Genomics and Diagnostics Cancer Research 0 works
  9. 9 Peripheral Neuropathies and Disorders Neurology 0 works
  10. 10 Immunotherapy and Immune Responses Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available81.4%not open18.6%

World: 28% of research is openly available.

with international co-authors100.0%

World: 19% is written across borders.

Other research institutions in Solan

All research institutions in Solan

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.